These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Acquisition of the pluripotent and trophectoderm states in the embryo and during somatic nuclear reprogramming. Jaber M; Sebban S; Buganim Y Curr Opin Genet Dev; 2017 Oct; 46():37-43. PubMed ID: 28662446 [TBL] [Abstract][Full Text] [Related]
24. Concise Review: Control of Cell Fate Through Cell Cycle and Pluripotency Networks. Boward B; Wu T; Dalton S Stem Cells; 2016 Jun; 34(6):1427-36. PubMed ID: 26889666 [TBL] [Abstract][Full Text] [Related]
25. Suppression of SIRT2 and altered acetylation status of human pluripotent stem cells: possible link to metabolic switch during reprogramming. Kwon OS; Han MJ; Cha HJ BMB Rep; 2017 Sep; 50(9):435-436. PubMed ID: 28683850 [TBL] [Abstract][Full Text] [Related]
26. Regulation of energy metabolism in human pluripotent stem cells. Liu W; Chen G Cell Mol Life Sci; 2021 Dec; 78(24):8097-8108. PubMed ID: 34773132 [TBL] [Abstract][Full Text] [Related]
27. Emerging roles of hypoxia-inducible factors and reactive oxygen species in cancer and pluripotent stem cells. Saito S; Lin YC; Tsai MH; Lin CS; Murayama Y; Sato R; Yokoyama KK Kaohsiung J Med Sci; 2015 Jun; 31(6):279-86. PubMed ID: 26043406 [TBL] [Abstract][Full Text] [Related]
28. Linking Telomere Regulation to Stem Cell Pluripotency. Liu L Trends Genet; 2017 Jan; 33(1):16-33. PubMed ID: 27889084 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-based system in stem cell reprogramming; differentiation/dedifferentiation. Pourrajab F; Babaei Zarch M; BaghiYazdi M; Hekmatimoghaddam S; Zare-Khormizi MR Int J Biochem Cell Biol; 2014 Oct; 55():318-28. PubMed ID: 25150833 [TBL] [Abstract][Full Text] [Related]
30. DNA Methylation is Correlated with Pluripotency of Stem Cells. Wang R; Li T Curr Stem Cell Res Ther; 2017; 12(6):442-446. PubMed ID: 28025937 [TBL] [Abstract][Full Text] [Related]
31. Revisiting Mitochondrial Function and Metabolism in Pluripotent Stem Cells: Where Do We Stand in Neurological Diseases? Lopes C; Rego AC Mol Neurobiol; 2017 Apr; 54(3):1858-1873. PubMed ID: 26892627 [TBL] [Abstract][Full Text] [Related]
32. Epigenetics of cell fate reprogramming and its implications for neurological disorders modelling. Grzybek M; Golonko A; Walczak M; Lisowski P Neurobiol Dis; 2017 Mar; 99():84-120. PubMed ID: 27890672 [TBL] [Abstract][Full Text] [Related]
33. Current status in cancer cell reprogramming and its clinical implications. Izgi K; Canatan H; Iskender B J Cancer Res Clin Oncol; 2017 Mar; 143(3):371-383. PubMed ID: 27620745 [TBL] [Abstract][Full Text] [Related]
34. Connecting Mitochondria, Metabolism, and Stem Cell Fate. Wanet A; Arnould T; Najimi M; Renard P Stem Cells Dev; 2015 Sep; 24(17):1957-71. PubMed ID: 26134242 [TBL] [Abstract][Full Text] [Related]